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Abstract 
 
Post hoc analysis of a large US population-based study of melanoma was carried 
out to test Whiteman’s divergent pathway model that suggests different etiologic 
pathways for melanoma based on (1) pattern of sun exposure, as characterized 
by anatomic site, and (2) host factors such as propensity for melanocyte 
proliferation, as characterized by nevus status. Study subjects consisted of 528 
newly diagnosed cases of melanoma among Caucasian residents of Connecticut. 
Nurse-interviewers obtained information on age, gender, hair color, eye color, 
skin color, history of sun exposure, history of painful sunburns, anatomic site of 
melanoma, and number of nevi on both arms and the back. Age-adjusted 
simultaneous odds ratios with 95% confidence intervals were generated using 
nevus status as the dependent variable. The study found a statistically significant 
relationship (p<0.01) exists between anatomic site of melanoma and having 
many nevi. This is consistent with the prediction of the divergent pathway 
model for different paths to melanoma formation based on pattern of sun 
exposure and host propensity for melanocyte proliferation. Further investigation 
into the biological basis for the divergent pathway is warranted so that skin 
cancer prevention strategies can be tailored to specific populations. 
Introduction 
     Cutaneous malignant melanoma, a tumor arising from melanocytes, is by far 
the most common fatal skin cancer (1). It is the fifth most common cancer 
among men and the seventh most common cancer among women in the United 
States (2). Moreover, the incidence of melanoma is rising more rapidly than that 
of any other cancer: the frequency of melanoma has increased by a factor of 15 
in the last 60 years (3).  
     Sun exposure is generally accepted as a major causative factor behind 
melanoma (5). However, the relationship is complex, as illustrated by apparent 
paradoxes in melanoma epidemiology. The prevalence of melanoma in 
susceptible populations has long been known to vary inversely with latitude of 
residence (6), yet measures of individual sun exposure have been inconsistently 
associated with melanoma (7). Indoor workers have a higher risk of melanoma 
than outdoor workers (8). Furthermore, a small proportion of melanomas arise in 
sites that are completely protected from the sun, such as the axillae (9). In sum, 
while pattern of sun exposure is recognized as an important determinant of 
melanoma, no consistent signature of ultraviolet exposure has been found in any 
gene mutated in melanoma and thus mechanisms mediated by processes other 
than direct absorption of ultraviolet light by DNA may contribute to progression 
to melanoma (10).  
     Differences in melanoma incidence and age-at-onset have been observed 
across anatomic site. These differences defy explanation based upon the pattern 
of sun exposure alone, i.e. chronic versus intermittent (11). It has therefore been 
suggested that the response of melanocytes to ultraviolet light varies depending 
on their location in the body (12). 
     Collectively, the evidence points to melanomas arising along distinct genetic 
pathways via a complex interaction of factors related to anatomy, heredity, and 
sun exposure (10). The recently proposed ‘divergent pathway’ model for 
development of cutaneous melanoma seeks to offer a unifying hypothesis for all 
of the epidemiologic and experimental data on melanoma (13).  It proposes two 
different pathways for the development of melanoma. In the first pathway, 
individuals with a low propensity for melanocyte proliferation, as characterized 
by a low nevus count, develop melanoma after chronic exposure to the sun. 
Hence, melanomas arising in these individuals will occur predominantly on 
habitually sun-exposed anatomic sites, such as the head, neck, and arms. In the 
second pathway, melanoma develops in individuals with a high propensity for 
melanocyte proliferation, as characterized by a high nevus count. In this group, 
sun exposure plus host factors leads to melanoma formation in intermittently-
exposed anatomic sites, such as the trunk. 
     The aim of the present study was to conduct post hoc analysis of a large, 
population-based case-control study of invasive malignant melanoma in 
Connecticut residents from 1987-1989 to query whether melanoma 
characteristics and risk factors differ across anatomic site as predicted by the 
‘divergent pathway’ model. 
 
 
Results 
     The demographic characteristics and histologic subtypes of the subjects are 
presented in Table 1.Age-adjusted simultaneous odds ratios with 95% 
confidence intervals were generated using nevus status as the dependent variable 
and are presented in Table 2. Anatomic site of melanoma predicted a high nevus 
count, with p<0.01. Melanomas in chronically sun-exposed sites predicted lower 
nevus count (95% CI 0.26 – 0.85), while melanomas in intermittently sun-
exposed sites such as the upper shoulder and back, lower back, chest and 
stomach had 95% CI overlapping with one. 
     Melanoma among males achieved a statistically significant associated with 
high nevus count (95% CI 1.07 – 2.39). No history of painful sunburns was also 
predictive of a high nevus count (95% CI 1.01 – 2.26). No other demographic 
characteristics or histologic subtypes were statistically significantly associated 
with high nevus count. 
 
Table 1. Demographic characteristics and histologic subtypes 
                      Variable
Melanoma in 
chronically 
sun-exposed 
site
Melanoma 
in 
intermittent
ly sun-
exposed 
site
Sex:   
       Male 50 238 
       Female 35 225 
Age    
       < 45 14 140 
       45 - 64 32 191 
       65+ 39 133 
Histologic subtype:   
       Lentigo maligna 49 33 
       Nodular 5 52 
       Superficial spreading 17 316 
       Other 13 54 
 
Table 2. Multivariate age-adjusted Odds Ratios with 95% Confidence Intervals 
for nevus count  
                      Variable Odds Ratio* 
95% 
CI
P-
Value
Anatomic site of 
melanoma: 
  0.006 
       Head, face, and neck 0.47 0.26 – 
0.85 
 
       Upper shoulder and 
back 
1.13 0.68 – 
1.87 
 
       Lower back  1.53 0.72 – 
3.26 
 
       Chest and stomach 0.77 0.39 – 
1.52 
 
Male gender 1.60 1.07 – 
2.39 
0.02 
No history of painful 
sunburns 
1.51 1.01 – 
2.26 
0.04 
       *Age-adjusted odds ratio 
 
Discussion 
The study found a statistically significant relationship (p<0.01) exists between 
anatomic site of melanoma and having many nevi. This is consistent with the 
prediction of the divergent pathway model for different paths to melanoma 
formation based on pattern of sun exposure and host propensity for melanocyte 
proliferation. However, nevus count was unable to predict anatomic site of 
melanoma (p<.06, unpublished results), which argues against clinical 
significance. The association between male gender and no history of painful 
sunburns with high nevus counts is not surprising given that males who develop 
melanoma have higher nevus counts. 
Given the finding that individuals with higher nevus counts are associated with 
anatomic site of melanoma, it may be that high nevus count is indicative of 
melanocyte instability. This could place individuals with unstable melanocytes 
at higher risk for development of melanoma as a result of intermittent sun 
exposure. On the other hand, individuals with stable melanocytes, as 
demonstrated by low nevus counts, are protected against this pathway of 
melanoma. They are susceptible to development of melanoma on chronically 
sun-exposed sites, such as the head, face, and neck. Further investigation into 
the biological basis for the divergent pathway is warranted so that skin cancer 
prevention strategies can be tailored to specific populations. 
Materials and Methods 
Cases for this study were obtained as previously described (14). Briefly, subjects 
consisted of newly diagnosed cases of melanoma among Caucasian residents of 
Connecticut between 1987 and 1989 as identified by the tumor registry. Nurse-
interviewers obtained information on age, gender, hair color, eye color, skin 
color, history of sun exposure, history of painful sunburns, anatomic site of 
melanoma, and number of nevi on both arms and the back. Pathologists 
examined specimens and determined the histologic subtype of each melanoma. 
Age-adjusted simultaneous odds ratios with 95% confidence intervals were 
generated using nevus status as the dependent variable. A high nevus count was 
defined as having more than eleven nevi counted on both arms and the back. 
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